Back

Image-based cardiac safety assessment, a novel approach to complement in vitro hiPSC-CM electrophysiology studies

29 April 2022 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Science - Poster session 1 Drugs, Drug Targets CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Brigitta Rita Szabo

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Deep molecular characterization of human induced pluripotent stem cell-derived atrial cardiomyocytes
Miss M. Casini (Valencia, ES)
Presentation thumbnail
Ischemia-selective protection against cardiac ischemia/reperfusion injury by malonate
Doctor H. Prag (Cambridge, GB)
Presentation thumbnail
Effect of angiotensin receptor neprilysin inhibitor and empagliflozin on systemic inflammation and scar remodeling in a swine model of chronic myocardial infarction
Doctor D. Martinez-Falguera (Badalona, ES)
Presentation thumbnail
M1 activated macrophages cause cardiac arrhythmia - an hiPSC-based in vitro model of inflammation associated atrial fibrillation
Mr T. Hutschalik (Maastricht, NL)

Access the full session

Session thumbnail
Late-Breaking Science - Poster session 1

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources